Venture Capital & Private Equity - Montreal, Québec, Canada
AgeChem Venture Fund L.P., with $65 million CDN under management, is seeking to invest in companies developing therapeutics targeting age-related diseases. Principally, AgeChem wishes to build a portfolio of Companies developing novel therapeutics to treat metabolic disorders (e.g. diabetes, obesity), cardiovascular diseases, cancers, diseases of the central nervous system (e.g. Alzheimer, Parkinson, insomnia), inflammatory diseases (e.g. rheumatoid arthritis, psoriasis), ophthalmic diseases and numerous other age-related diseases.In addition to AgeChem, the principals are managing 3 other funds, for a total committed capital under management of more than $370 million CDN.
Outlook
Apache
Microsoft Office 365